Uterine Fibroid Embolization Device Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Uterine Fibroid Embolization Device in global, including the following market information:
Global Uterine Fibroid Embolization Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Uterine Fibroid Embolization Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Uterine Fibroid Embolization Device companies in 2021 (%)
The global Uterine Fibroid Embolization Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gelatin Sponge Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Uterine Fibroid Embolization Device include Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., Cook Medical, Ferring B.V., Smith+Nephew, CooperSurgical, Inc. and Aetna Better Health of Pennsylvania, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Uterine Fibroid Embolization Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Uterine Fibroid Embolization Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Uterine Fibroid Embolization Device Market Segment Percentages, by Type, 2021 (%)
Global Uterine Fibroid Embolization Device Market Segment Percentages, by Application, 2021 (%)
Global Uterine Fibroid Embolization Device Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Uterine Fibroid Embolization Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Uterine Fibroid Embolization Device revenues share in global market, 2021 (%)
Key companies Uterine Fibroid Embolization Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Uterine Fibroid Embolization Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Uterine Fibroid Embolization Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Uterine Fibroid Embolization Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Uterine Fibroid Embolization Device companies in 2021 (%)
The global Uterine Fibroid Embolization Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gelatin Sponge Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Uterine Fibroid Embolization Device include Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., Cook Medical, Ferring B.V., Smith+Nephew, CooperSurgical, Inc. and Aetna Better Health of Pennsylvania, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Uterine Fibroid Embolization Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Uterine Fibroid Embolization Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Uterine Fibroid Embolization Device Market Segment Percentages, by Type, 2021 (%)
- Gelatin Sponge
- Polyvinyl Alcohol ( PVA ) Particles
- Trisacryl Gelatin Microspheres ( TAGM )
- Polymethyl Methacrylate ( PMMA ) Microspheres
Global Uterine Fibroid Embolization Device Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
Global Uterine Fibroid Embolization Device Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Uterine Fibroid Embolization Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Uterine Fibroid Embolization Device revenues share in global market, 2021 (%)
Key companies Uterine Fibroid Embolization Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Uterine Fibroid Embolization Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boston Scientific Corporation
- Merit Medical Systems
- BioSpace
- Hologic, Inc.
- Cook Medical
- Ferring B.V.
- Smith+Nephew
- CooperSurgical, Inc.
- Aetna Better Health of Pennsylvania
- Ethicon US, LLC
- Olympus America
- Stryker
- Astellas Pharma
- Nippon Kayaku
- Pfizer
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Uterine Fibroid Embolization Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Uterine Fibroid Embolization Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL UTERINE FIBROID EMBOLIZATION DEVICE OVERALL MARKET SIZE
2.1 Global Uterine Fibroid Embolization Device Market Size: 2021 VS 2028
2.2 Global Uterine Fibroid Embolization Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Uterine Fibroid Embolization Device Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Uterine Fibroid Embolization Device Players in Global Market
3.2 Top Global Uterine Fibroid Embolization Device Companies Ranked by Revenue
3.3 Global Uterine Fibroid Embolization Device Revenue by Companies
3.4 Global Uterine Fibroid Embolization Device Sales by Companies
3.5 Global Uterine Fibroid Embolization Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Uterine Fibroid Embolization Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Uterine Fibroid Embolization Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Uterine Fibroid Embolization Device Players in Global Market
3.8.1 List of Global Tier 1 Uterine Fibroid Embolization Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Uterine Fibroid Embolization Device Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Uterine Fibroid Embolization Device Market Size Markets, 2021 & 2028
4.1.2 Gelatin Sponge
4.1.3 Polyvinyl Alcohol ( PVA ) Particles
4.1.4 Trisacryl Gelatin Microspheres ( TAGM )
4.1.5 Polymethyl Methacrylate ( PMMA ) Microspheres
4.2 By Type - Global Uterine Fibroid Embolization Device Revenue & Forecasts
4.2.1 By Type - Global Uterine Fibroid Embolization Device Revenue, 2017-2022
4.2.2 By Type - Global Uterine Fibroid Embolization Device Revenue, 2023-2028
4.2.3 By Type - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
4.3 By Type - Global Uterine Fibroid Embolization Device Sales & Forecasts
4.3.1 By Type - Global Uterine Fibroid Embolization Device Sales, 2017-2022
4.3.2 By Type - Global Uterine Fibroid Embolization Device Sales, 2023-2028
4.3.3 By Type - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
4.4 By Type - Global Uterine Fibroid Embolization Device Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Uterine Fibroid Embolization Device Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Uterine Fibroid Embolization Device Revenue & Forecasts
5.2.1 By Application - Global Uterine Fibroid Embolization Device Revenue, 2017-2022
5.2.2 By Application - Global Uterine Fibroid Embolization Device Revenue, 2023-2028
5.2.3 By Application - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
5.3 By Application - Global Uterine Fibroid Embolization Device Sales & Forecasts
5.3.1 By Application - Global Uterine Fibroid Embolization Device Sales, 2017-2022
5.3.2 By Application - Global Uterine Fibroid Embolization Device Sales, 2023-2028
5.3.3 By Application - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
5.4 By Application - Global Uterine Fibroid Embolization Device Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Uterine Fibroid Embolization Device Market Size, 2021 & 2028
6.2 By Region - Global Uterine Fibroid Embolization Device Revenue & Forecasts
6.2.1 By Region - Global Uterine Fibroid Embolization Device Revenue, 2017-2022
6.2.2 By Region - Global Uterine Fibroid Embolization Device Revenue, 2023-2028
6.2.3 By Region - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
6.3 By Region - Global Uterine Fibroid Embolization Device Sales & Forecasts
6.3.1 By Region - Global Uterine Fibroid Embolization Device Sales, 2017-2022
6.3.2 By Region - Global Uterine Fibroid Embolization Device Sales, 2023-2028
6.3.3 By Region - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Uterine Fibroid Embolization Device Revenue, 2017-2028
6.4.2 By Country - North America Uterine Fibroid Embolization Device Sales, 2017-2028
6.4.3 US Uterine Fibroid Embolization Device Market Size, 2017-2028
6.4.4 Canada Uterine Fibroid Embolization Device Market Size, 2017-2028
6.4.5 Mexico Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Uterine Fibroid Embolization Device Revenue, 2017-2028
6.5.2 By Country - Europe Uterine Fibroid Embolization Device Sales, 2017-2028
6.5.3 Germany Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.4 France Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.5 U.K. Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.6 Italy Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.7 Russia Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.8 Nordic Countries Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.9 Benelux Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Uterine Fibroid Embolization Device Revenue, 2017-2028
6.6.2 By Region - Asia Uterine Fibroid Embolization Device Sales, 2017-2028
6.6.3 China Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.4 Japan Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.5 South Korea Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.6 Southeast Asia Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.7 India Uterine Fibroid Embolization Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Uterine Fibroid Embolization Device Revenue, 2017-2028
6.7.2 By Country - South America Uterine Fibroid Embolization Device Sales, 2017-2028
6.7.3 Brazil Uterine Fibroid Embolization Device Market Size, 2017-2028
6.7.4 Argentina Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales, 2017-2028
6.8.3 Turkey Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8.4 Israel Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8.5 Saudi Arabia Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8.6 UAE Uterine Fibroid Embolization Device Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Boston Scientific Corporation
7.1.1 Boston Scientific Corporation Corporate Summary
7.1.2 Boston Scientific Corporation Business Overview
7.1.3 Boston Scientific Corporation Uterine Fibroid Embolization Device Major Product Offerings
7.1.4 Boston Scientific Corporation Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.1.5 Boston Scientific Corporation Key News
7.2 Merit Medical Systems
7.2.1 Merit Medical Systems Corporate Summary
7.2.2 Merit Medical Systems Business Overview
7.2.3 Merit Medical Systems Uterine Fibroid Embolization Device Major Product Offerings
7.2.4 Merit Medical Systems Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.2.5 Merit Medical Systems Key News
7.3 BioSpace
7.3.1 BioSpace Corporate Summary
7.3.2 BioSpace Business Overview
7.3.3 BioSpace Uterine Fibroid Embolization Device Major Product Offerings
7.3.4 BioSpace Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.3.5 BioSpace Key News
7.4 Hologic, Inc.
7.4.1 Hologic, Inc. Corporate Summary
7.4.2 Hologic, Inc. Business Overview
7.4.3 Hologic, Inc. Uterine Fibroid Embolization Device Major Product Offerings
7.4.4 Hologic, Inc. Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.4.5 Hologic, Inc. Key News
7.5 Cook Medical
7.5.1 Cook Medical Corporate Summary
7.5.2 Cook Medical Business Overview
7.5.3 Cook Medical Uterine Fibroid Embolization Device Major Product Offerings
7.5.4 Cook Medical Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.5.5 Cook Medical Key News
7.6 Ferring B.V.
7.6.1 Ferring B.V. Corporate Summary
7.6.2 Ferring B.V. Business Overview
7.6.3 Ferring B.V. Uterine Fibroid Embolization Device Major Product Offerings
7.6.4 Ferring B.V. Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.6.5 Ferring B.V. Key News
7.7 Smith+Nephew
7.7.1 Smith+Nephew Corporate Summary
7.7.2 Smith+Nephew Business Overview
7.7.3 Smith+Nephew Uterine Fibroid Embolization Device Major Product Offerings
7.7.4 Smith+Nephew Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.7.5 Smith+Nephew Key News
7.8 CooperSurgical, Inc.
7.8.1 CooperSurgical, Inc. Corporate Summary
7.8.2 CooperSurgical, Inc. Business Overview
7.8.3 CooperSurgical, Inc. Uterine Fibroid Embolization Device Major Product Offerings
7.8.4 CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.8.5 CooperSurgical, Inc. Key News
7.9 Aetna Better Health of Pennsylvania
7.9.1 Aetna Better Health of Pennsylvania Corporate Summary
7.9.2 Aetna Better Health of Pennsylvania Business Overview
7.9.3 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Major Product Offerings
7.9.4 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.9.5 Aetna Better Health of Pennsylvania Key News
7.10 Ethicon US, LLC
7.10.1 Ethicon US, LLC Corporate Summary
7.10.2 Ethicon US, LLC Business Overview
7.10.3 Ethicon US, LLC Uterine Fibroid Embolization Device Major Product Offerings
7.10.4 Ethicon US, LLC Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.10.5 Ethicon US, LLC Key News
7.11 Olympus America
7.11.1 Olympus America Corporate Summary
7.11.2 Olympus America Uterine Fibroid Embolization Device Business Overview
7.11.3 Olympus America Uterine Fibroid Embolization Device Major Product Offerings
7.11.4 Olympus America Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.11.5 Olympus America Key News
7.12 Stryker
7.12.1 Stryker Corporate Summary
7.12.2 Stryker Uterine Fibroid Embolization Device Business Overview
7.12.3 Stryker Uterine Fibroid Embolization Device Major Product Offerings
7.12.4 Stryker Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.12.5 Stryker Key News
7.13 Astellas Pharma
7.13.1 Astellas Pharma Corporate Summary
7.13.2 Astellas Pharma Uterine Fibroid Embolization Device Business Overview
7.13.3 Astellas Pharma Uterine Fibroid Embolization Device Major Product Offerings
7.13.4 Astellas Pharma Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.13.5 Astellas Pharma Key News
7.14 Nippon Kayaku
7.14.1 Nippon Kayaku Corporate Summary
7.14.2 Nippon Kayaku Business Overview
7.14.3 Nippon Kayaku Uterine Fibroid Embolization Device Major Product Offerings
7.14.4 Nippon Kayaku Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.14.5 Nippon Kayaku Key News
7.15 Pfizer
7.15.1 Pfizer Corporate Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Uterine Fibroid Embolization Device Major Product Offerings
7.15.4 Pfizer Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.15.5 Pfizer Key News
8 GLOBAL UTERINE FIBROID EMBOLIZATION DEVICE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Uterine Fibroid Embolization Device Production Capacity, 2017-2028
8.2 Uterine Fibroid Embolization Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Uterine Fibroid Embolization Device Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 UTERINE FIBROID EMBOLIZATION DEVICE SUPPLY CHAIN ANALYSIS
10.1 Uterine Fibroid Embolization Device Industry Value Chain
10.2 Uterine Fibroid Embolization Device Upstream Market
10.3 Uterine Fibroid Embolization Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Uterine Fibroid Embolization Device Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Uterine Fibroid Embolization Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Uterine Fibroid Embolization Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL UTERINE FIBROID EMBOLIZATION DEVICE OVERALL MARKET SIZE
2.1 Global Uterine Fibroid Embolization Device Market Size: 2021 VS 2028
2.2 Global Uterine Fibroid Embolization Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Uterine Fibroid Embolization Device Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Uterine Fibroid Embolization Device Players in Global Market
3.2 Top Global Uterine Fibroid Embolization Device Companies Ranked by Revenue
3.3 Global Uterine Fibroid Embolization Device Revenue by Companies
3.4 Global Uterine Fibroid Embolization Device Sales by Companies
3.5 Global Uterine Fibroid Embolization Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Uterine Fibroid Embolization Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Uterine Fibroid Embolization Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Uterine Fibroid Embolization Device Players in Global Market
3.8.1 List of Global Tier 1 Uterine Fibroid Embolization Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Uterine Fibroid Embolization Device Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Uterine Fibroid Embolization Device Market Size Markets, 2021 & 2028
4.1.2 Gelatin Sponge
4.1.3 Polyvinyl Alcohol ( PVA ) Particles
4.1.4 Trisacryl Gelatin Microspheres ( TAGM )
4.1.5 Polymethyl Methacrylate ( PMMA ) Microspheres
4.2 By Type - Global Uterine Fibroid Embolization Device Revenue & Forecasts
4.2.1 By Type - Global Uterine Fibroid Embolization Device Revenue, 2017-2022
4.2.2 By Type - Global Uterine Fibroid Embolization Device Revenue, 2023-2028
4.2.3 By Type - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
4.3 By Type - Global Uterine Fibroid Embolization Device Sales & Forecasts
4.3.1 By Type - Global Uterine Fibroid Embolization Device Sales, 2017-2022
4.3.2 By Type - Global Uterine Fibroid Embolization Device Sales, 2023-2028
4.3.3 By Type - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
4.4 By Type - Global Uterine Fibroid Embolization Device Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Uterine Fibroid Embolization Device Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Uterine Fibroid Embolization Device Revenue & Forecasts
5.2.1 By Application - Global Uterine Fibroid Embolization Device Revenue, 2017-2022
5.2.2 By Application - Global Uterine Fibroid Embolization Device Revenue, 2023-2028
5.2.3 By Application - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
5.3 By Application - Global Uterine Fibroid Embolization Device Sales & Forecasts
5.3.1 By Application - Global Uterine Fibroid Embolization Device Sales, 2017-2022
5.3.2 By Application - Global Uterine Fibroid Embolization Device Sales, 2023-2028
5.3.3 By Application - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
5.4 By Application - Global Uterine Fibroid Embolization Device Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Uterine Fibroid Embolization Device Market Size, 2021 & 2028
6.2 By Region - Global Uterine Fibroid Embolization Device Revenue & Forecasts
6.2.1 By Region - Global Uterine Fibroid Embolization Device Revenue, 2017-2022
6.2.2 By Region - Global Uterine Fibroid Embolization Device Revenue, 2023-2028
6.2.3 By Region - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
6.3 By Region - Global Uterine Fibroid Embolization Device Sales & Forecasts
6.3.1 By Region - Global Uterine Fibroid Embolization Device Sales, 2017-2022
6.3.2 By Region - Global Uterine Fibroid Embolization Device Sales, 2023-2028
6.3.3 By Region - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Uterine Fibroid Embolization Device Revenue, 2017-2028
6.4.2 By Country - North America Uterine Fibroid Embolization Device Sales, 2017-2028
6.4.3 US Uterine Fibroid Embolization Device Market Size, 2017-2028
6.4.4 Canada Uterine Fibroid Embolization Device Market Size, 2017-2028
6.4.5 Mexico Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Uterine Fibroid Embolization Device Revenue, 2017-2028
6.5.2 By Country - Europe Uterine Fibroid Embolization Device Sales, 2017-2028
6.5.3 Germany Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.4 France Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.5 U.K. Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.6 Italy Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.7 Russia Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.8 Nordic Countries Uterine Fibroid Embolization Device Market Size, 2017-2028
6.5.9 Benelux Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Uterine Fibroid Embolization Device Revenue, 2017-2028
6.6.2 By Region - Asia Uterine Fibroid Embolization Device Sales, 2017-2028
6.6.3 China Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.4 Japan Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.5 South Korea Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.6 Southeast Asia Uterine Fibroid Embolization Device Market Size, 2017-2028
6.6.7 India Uterine Fibroid Embolization Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Uterine Fibroid Embolization Device Revenue, 2017-2028
6.7.2 By Country - South America Uterine Fibroid Embolization Device Sales, 2017-2028
6.7.3 Brazil Uterine Fibroid Embolization Device Market Size, 2017-2028
6.7.4 Argentina Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales, 2017-2028
6.8.3 Turkey Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8.4 Israel Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8.5 Saudi Arabia Uterine Fibroid Embolization Device Market Size, 2017-2028
6.8.6 UAE Uterine Fibroid Embolization Device Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Boston Scientific Corporation
7.1.1 Boston Scientific Corporation Corporate Summary
7.1.2 Boston Scientific Corporation Business Overview
7.1.3 Boston Scientific Corporation Uterine Fibroid Embolization Device Major Product Offerings
7.1.4 Boston Scientific Corporation Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.1.5 Boston Scientific Corporation Key News
7.2 Merit Medical Systems
7.2.1 Merit Medical Systems Corporate Summary
7.2.2 Merit Medical Systems Business Overview
7.2.3 Merit Medical Systems Uterine Fibroid Embolization Device Major Product Offerings
7.2.4 Merit Medical Systems Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.2.5 Merit Medical Systems Key News
7.3 BioSpace
7.3.1 BioSpace Corporate Summary
7.3.2 BioSpace Business Overview
7.3.3 BioSpace Uterine Fibroid Embolization Device Major Product Offerings
7.3.4 BioSpace Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.3.5 BioSpace Key News
7.4 Hologic, Inc.
7.4.1 Hologic, Inc. Corporate Summary
7.4.2 Hologic, Inc. Business Overview
7.4.3 Hologic, Inc. Uterine Fibroid Embolization Device Major Product Offerings
7.4.4 Hologic, Inc. Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.4.5 Hologic, Inc. Key News
7.5 Cook Medical
7.5.1 Cook Medical Corporate Summary
7.5.2 Cook Medical Business Overview
7.5.3 Cook Medical Uterine Fibroid Embolization Device Major Product Offerings
7.5.4 Cook Medical Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.5.5 Cook Medical Key News
7.6 Ferring B.V.
7.6.1 Ferring B.V. Corporate Summary
7.6.2 Ferring B.V. Business Overview
7.6.3 Ferring B.V. Uterine Fibroid Embolization Device Major Product Offerings
7.6.4 Ferring B.V. Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.6.5 Ferring B.V. Key News
7.7 Smith+Nephew
7.7.1 Smith+Nephew Corporate Summary
7.7.2 Smith+Nephew Business Overview
7.7.3 Smith+Nephew Uterine Fibroid Embolization Device Major Product Offerings
7.7.4 Smith+Nephew Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.7.5 Smith+Nephew Key News
7.8 CooperSurgical, Inc.
7.8.1 CooperSurgical, Inc. Corporate Summary
7.8.2 CooperSurgical, Inc. Business Overview
7.8.3 CooperSurgical, Inc. Uterine Fibroid Embolization Device Major Product Offerings
7.8.4 CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.8.5 CooperSurgical, Inc. Key News
7.9 Aetna Better Health of Pennsylvania
7.9.1 Aetna Better Health of Pennsylvania Corporate Summary
7.9.2 Aetna Better Health of Pennsylvania Business Overview
7.9.3 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Major Product Offerings
7.9.4 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.9.5 Aetna Better Health of Pennsylvania Key News
7.10 Ethicon US, LLC
7.10.1 Ethicon US, LLC Corporate Summary
7.10.2 Ethicon US, LLC Business Overview
7.10.3 Ethicon US, LLC Uterine Fibroid Embolization Device Major Product Offerings
7.10.4 Ethicon US, LLC Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.10.5 Ethicon US, LLC Key News
7.11 Olympus America
7.11.1 Olympus America Corporate Summary
7.11.2 Olympus America Uterine Fibroid Embolization Device Business Overview
7.11.3 Olympus America Uterine Fibroid Embolization Device Major Product Offerings
7.11.4 Olympus America Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.11.5 Olympus America Key News
7.12 Stryker
7.12.1 Stryker Corporate Summary
7.12.2 Stryker Uterine Fibroid Embolization Device Business Overview
7.12.3 Stryker Uterine Fibroid Embolization Device Major Product Offerings
7.12.4 Stryker Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.12.5 Stryker Key News
7.13 Astellas Pharma
7.13.1 Astellas Pharma Corporate Summary
7.13.2 Astellas Pharma Uterine Fibroid Embolization Device Business Overview
7.13.3 Astellas Pharma Uterine Fibroid Embolization Device Major Product Offerings
7.13.4 Astellas Pharma Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.13.5 Astellas Pharma Key News
7.14 Nippon Kayaku
7.14.1 Nippon Kayaku Corporate Summary
7.14.2 Nippon Kayaku Business Overview
7.14.3 Nippon Kayaku Uterine Fibroid Embolization Device Major Product Offerings
7.14.4 Nippon Kayaku Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.14.5 Nippon Kayaku Key News
7.15 Pfizer
7.15.1 Pfizer Corporate Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Uterine Fibroid Embolization Device Major Product Offerings
7.15.4 Pfizer Uterine Fibroid Embolization Device Sales and Revenue in Global (2017-2022)
7.15.5 Pfizer Key News
8 GLOBAL UTERINE FIBROID EMBOLIZATION DEVICE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Uterine Fibroid Embolization Device Production Capacity, 2017-2028
8.2 Uterine Fibroid Embolization Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Uterine Fibroid Embolization Device Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 UTERINE FIBROID EMBOLIZATION DEVICE SUPPLY CHAIN ANALYSIS
10.1 Uterine Fibroid Embolization Device Industry Value Chain
10.2 Uterine Fibroid Embolization Device Upstream Market
10.3 Uterine Fibroid Embolization Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Uterine Fibroid Embolization Device Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Uterine Fibroid Embolization Device in Global Market
Table 2. Top Uterine Fibroid Embolization Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Uterine Fibroid Embolization Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Uterine Fibroid Embolization Device Revenue Share by Companies, 2017-2022
Table 5. Global Uterine Fibroid Embolization Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Uterine Fibroid Embolization Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Uterine Fibroid Embolization Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Uterine Fibroid Embolization Device Product Type
Table 9. List of Global Tier 1 Uterine Fibroid Embolization Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Uterine Fibroid Embolization Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Uterine Fibroid Embolization Device Sales (K Units), 2017-2022
Table 15. By Type - Global Uterine Fibroid Embolization Device Sales (K Units), 2023-2028
Table 16. By Application – Global Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Uterine Fibroid Embolization Device Sales (K Units), 2017-2022
Table 20. By Application - Global Uterine Fibroid Embolization Device Sales (K Units), 2023-2028
Table 21. By Region – Global Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Uterine Fibroid Embolization Device Sales (K Units), 2017-2022
Table 25. By Region - Global Uterine Fibroid Embolization Device Sales (K Units), 2023-2028
Table 26. By Country - North America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 46. Boston Scientific Corporation Corporate Summary
Table 47. Boston Scientific Corporation Uterine Fibroid Embolization Device Product Offerings
Table 48. Boston Scientific Corporation Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merit Medical Systems Corporate Summary
Table 50. Merit Medical Systems Uterine Fibroid Embolization Device Product Offerings
Table 51. Merit Medical Systems Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BioSpace Corporate Summary
Table 53. BioSpace Uterine Fibroid Embolization Device Product Offerings
Table 54. BioSpace Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Hologic, Inc. Corporate Summary
Table 56. Hologic, Inc. Uterine Fibroid Embolization Device Product Offerings
Table 57. Hologic, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Cook Medical Corporate Summary
Table 59. Cook Medical Uterine Fibroid Embolization Device Product Offerings
Table 60. Cook Medical Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ferring B.V. Corporate Summary
Table 62. Ferring B.V. Uterine Fibroid Embolization Device Product Offerings
Table 63. Ferring B.V. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Smith+Nephew Corporate Summary
Table 65. Smith+Nephew Uterine Fibroid Embolization Device Product Offerings
Table 66. Smith+Nephew Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CooperSurgical, Inc. Corporate Summary
Table 68. CooperSurgical, Inc. Uterine Fibroid Embolization Device Product Offerings
Table 69. CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Aetna Better Health of Pennsylvania Corporate Summary
Table 71. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product Offerings
Table 72. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Ethicon US, LLC Corporate Summary
Table 74. Ethicon US, LLC Uterine Fibroid Embolization Device Product Offerings
Table 75. Ethicon US, LLC Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Olympus America Corporate Summary
Table 77. Olympus America Uterine Fibroid Embolization Device Product Offerings
Table 78. Olympus America Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Stryker Corporate Summary
Table 80. Stryker Uterine Fibroid Embolization Device Product Offerings
Table 81. Stryker Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Astellas Pharma Corporate Summary
Table 83. Astellas Pharma Uterine Fibroid Embolization Device Product Offerings
Table 84. Astellas Pharma Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Nippon Kayaku Corporate Summary
Table 86. Nippon Kayaku Uterine Fibroid Embolization Device Product Offerings
Table 87. Nippon Kayaku Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Pfizer Corporate Summary
Table 89. Pfizer Uterine Fibroid Embolization Device Product Offerings
Table 90. Pfizer Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Uterine Fibroid Embolization Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 92. Global Uterine Fibroid Embolization Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Uterine Fibroid Embolization Device Production by Region, 2017-2022 (K Units)
Table 94. Global Uterine Fibroid Embolization Device Production by Region, 2023-2028 (K Units)
Table 95. Uterine Fibroid Embolization Device Market Opportunities & Trends in Global Market
Table 96. Uterine Fibroid Embolization Device Market Drivers in Global Market
Table 97. Uterine Fibroid Embolization Device Market Restraints in Global Market
Table 98. Uterine Fibroid Embolization Device Raw Materials
Table 99. Uterine Fibroid Embolization Device Raw Materials Suppliers in Global Market
Table 100. Typical Uterine Fibroid Embolization Device Downstream
Table 101. Uterine Fibroid Embolization Device Downstream Clients in Global Market
Table 102. Uterine Fibroid Embolization Device Distributors and Sales Agents in Global Market
Table 1. Key Players of Uterine Fibroid Embolization Device in Global Market
Table 2. Top Uterine Fibroid Embolization Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Uterine Fibroid Embolization Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Uterine Fibroid Embolization Device Revenue Share by Companies, 2017-2022
Table 5. Global Uterine Fibroid Embolization Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Uterine Fibroid Embolization Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Uterine Fibroid Embolization Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Uterine Fibroid Embolization Device Product Type
Table 9. List of Global Tier 1 Uterine Fibroid Embolization Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Uterine Fibroid Embolization Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Uterine Fibroid Embolization Device Sales (K Units), 2017-2022
Table 15. By Type - Global Uterine Fibroid Embolization Device Sales (K Units), 2023-2028
Table 16. By Application – Global Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Uterine Fibroid Embolization Device Sales (K Units), 2017-2022
Table 20. By Application - Global Uterine Fibroid Embolization Device Sales (K Units), 2023-2028
Table 21. By Region – Global Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Uterine Fibroid Embolization Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Uterine Fibroid Embolization Device Sales (K Units), 2017-2022
Table 25. By Region - Global Uterine Fibroid Embolization Device Sales (K Units), 2023-2028
Table 26. By Country - North America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales, (K Units), 2023-2028
Table 46. Boston Scientific Corporation Corporate Summary
Table 47. Boston Scientific Corporation Uterine Fibroid Embolization Device Product Offerings
Table 48. Boston Scientific Corporation Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merit Medical Systems Corporate Summary
Table 50. Merit Medical Systems Uterine Fibroid Embolization Device Product Offerings
Table 51. Merit Medical Systems Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BioSpace Corporate Summary
Table 53. BioSpace Uterine Fibroid Embolization Device Product Offerings
Table 54. BioSpace Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Hologic, Inc. Corporate Summary
Table 56. Hologic, Inc. Uterine Fibroid Embolization Device Product Offerings
Table 57. Hologic, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Cook Medical Corporate Summary
Table 59. Cook Medical Uterine Fibroid Embolization Device Product Offerings
Table 60. Cook Medical Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ferring B.V. Corporate Summary
Table 62. Ferring B.V. Uterine Fibroid Embolization Device Product Offerings
Table 63. Ferring B.V. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Smith+Nephew Corporate Summary
Table 65. Smith+Nephew Uterine Fibroid Embolization Device Product Offerings
Table 66. Smith+Nephew Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CooperSurgical, Inc. Corporate Summary
Table 68. CooperSurgical, Inc. Uterine Fibroid Embolization Device Product Offerings
Table 69. CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Aetna Better Health of Pennsylvania Corporate Summary
Table 71. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product Offerings
Table 72. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Ethicon US, LLC Corporate Summary
Table 74. Ethicon US, LLC Uterine Fibroid Embolization Device Product Offerings
Table 75. Ethicon US, LLC Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Olympus America Corporate Summary
Table 77. Olympus America Uterine Fibroid Embolization Device Product Offerings
Table 78. Olympus America Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Stryker Corporate Summary
Table 80. Stryker Uterine Fibroid Embolization Device Product Offerings
Table 81. Stryker Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Astellas Pharma Corporate Summary
Table 83. Astellas Pharma Uterine Fibroid Embolization Device Product Offerings
Table 84. Astellas Pharma Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Nippon Kayaku Corporate Summary
Table 86. Nippon Kayaku Uterine Fibroid Embolization Device Product Offerings
Table 87. Nippon Kayaku Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Pfizer Corporate Summary
Table 89. Pfizer Uterine Fibroid Embolization Device Product Offerings
Table 90. Pfizer Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Uterine Fibroid Embolization Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 92. Global Uterine Fibroid Embolization Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Uterine Fibroid Embolization Device Production by Region, 2017-2022 (K Units)
Table 94. Global Uterine Fibroid Embolization Device Production by Region, 2023-2028 (K Units)
Table 95. Uterine Fibroid Embolization Device Market Opportunities & Trends in Global Market
Table 96. Uterine Fibroid Embolization Device Market Drivers in Global Market
Table 97. Uterine Fibroid Embolization Device Market Restraints in Global Market
Table 98. Uterine Fibroid Embolization Device Raw Materials
Table 99. Uterine Fibroid Embolization Device Raw Materials Suppliers in Global Market
Table 100. Typical Uterine Fibroid Embolization Device Downstream
Table 101. Uterine Fibroid Embolization Device Downstream Clients in Global Market
Table 102. Uterine Fibroid Embolization Device Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Uterine Fibroid Embolization Device Segment by Type
Figure 2. Uterine Fibroid Embolization Device Segment by Application
Figure 3. Global Uterine Fibroid Embolization Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Uterine Fibroid Embolization Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Uterine Fibroid Embolization Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Uterine Fibroid Embolization Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Uterine Fibroid Embolization Device Revenue in 2021
Figure 9. By Type - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Uterine Fibroid Embolization Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Uterine Fibroid Embolization Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 19. US Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 24. Germany Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 33. China Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 40. Brazil Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 44. Turkey Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Uterine Fibroid Embolization Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Uterine Fibroid Embolization Device by Region, 2021 VS 2028
Figure 50. Uterine Fibroid Embolization Device Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Uterine Fibroid Embolization Device Segment by Type
Figure 2. Uterine Fibroid Embolization Device Segment by Application
Figure 3. Global Uterine Fibroid Embolization Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Uterine Fibroid Embolization Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Uterine Fibroid Embolization Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Uterine Fibroid Embolization Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Uterine Fibroid Embolization Device Revenue in 2021
Figure 9. By Type - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Uterine Fibroid Embolization Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Uterine Fibroid Embolization Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 19. US Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 24. Germany Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 33. China Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 40. Brazil Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Uterine Fibroid Embolization Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share, 2017-2028
Figure 44. Turkey Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Uterine Fibroid Embolization Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Uterine Fibroid Embolization Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Uterine Fibroid Embolization Device by Region, 2021 VS 2028
Figure 50. Uterine Fibroid Embolization Device Industry Value Chain
Figure 51. Marketing Channels
